drugset / Trial / NCT00354172

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

NCT00354172

Phase 2 Terminated 16 enrolled Masonic Cancer Center, University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the growth of abnormal cells and cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving cyclosporine, mycophenolate mofetil, and methylprednisolone before and after transplant may stop this from happening. PURPOSE: This clinical trial is studying how well giving fludarabine and cyclophosphamide together with total-body irradiation followed by donor umbilical cord blood natural killer cells, aldesleukin, and umbilical cord blood transplant works in treating patients with refractory hematologic cancer or other diseases.

Timeline

Start
2006-02
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject TROCULEUCEL Cell therapy 7e+08 cells
Background Cyclophosphamide Other / unclassified 60 mg/kg Intravenous
Background Cyclosporine Peptide 2.5 mg/kg Intravenous
Background Fludarabine Small molecule 25 mg/m2 Intravenous
Background Methylprednisolone Other / unclassified 1000 mg Intravenous
Background Mycophenolate Mofetil Small molecule 15 mg/kg Intravenous
Background Mycophenolate Mofetil Small molecule 3 g Intravenous
Background aldesleukin Protein / enzyme biologic 5 unknown Subcutaneous
Background aldesleukin Protein / enzyme biologic 1e+07 iu Subcutaneous
Background filgrastim Protein / enzyme biologic 5 ug/kg Intravenous